Literature DB >> 26423788

Metabolic approaches to antihypertensive treatment in diabetic patients.

Arrigo F Cicero1, Giuliano Tocci2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26423788     DOI: 10.1038/hr.2015.105

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  12 in total

1.  Hypertension and diabetes incidence: confounding factors.

Authors:  Arrigo F G Cicero; Sibel Ertek
Journal:  Hypertens Res       Date:  2011-07-14       Impact factor: 3.872

Review 2.  From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century.

Authors:  Matthias Blüher; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-10-23       Impact factor: 8.694

Review 3.  Hypertension: management perspectives.

Authors:  Claudio Borghi; Arrigo F G Cicero
Journal:  Expert Opin Pharmacother       Date:  2012-07-18       Impact factor: 3.889

4.  Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.

Authors:  Giuseppe Derosa; Fabrizio Querci; Ivano Franzetti; Pietro Dario Ragonesi; Angela D'Angelo; Pamela Maffioli
Journal:  Hypertens Res       Date:  2015-05-21       Impact factor: 3.872

5.  Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells.

Authors:  Daisuke Mikami; Hideki Kimura; Kazuko Kamiyama; Kunio Torii; Kenji Kasuno; Naoki Takahashi; Haruyoshi Yoshida; Masayuki Iwano
Journal:  Hypertens Res       Date:  2013-12-19       Impact factor: 3.872

Review 6.  Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials.

Authors:  Hisato Takagi; Yusuke Mizuno; Hirotaka Yamamoto; Shin-nosuke Goto; Takuya Umemoto
Journal:  Hypertens Res       Date:  2012-12-13       Impact factor: 3.872

7.  Attitudes and preferences for the clinical management of hypertension and hypertension-related cardiac disease in general practice: results of the Italian Hypertension and Heart Survey.

Authors:  G Tocci; A F Cicero; M Salvetti; P Francia; A Ferrucci; C Borghi; M Volpe
Journal:  J Hum Hypertens       Date:  2014-12-18       Impact factor: 3.012

8.  2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.

Authors: 
Journal:  J Hypertens       Date:  2013-10       Impact factor: 4.844

9.  Challenge for hypertension prevention and control worldwide: the time for action.

Authors:  Daniel Lemogoum
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-07-24       Impact factor: 3.738

10.  The metabolic cost of lowering blood pressure with hydrochlorothiazide.

Authors:  Angela L Price; Ildiko Lingvay; Edward W Szczepaniak; Jaime Wiebel; Ronald G Victor; Lidia S Szczepaniak
Journal:  Diabetol Metab Syndr       Date:  2013-07-09       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.